Impact of KIR/KIR ligand genotype for neuroblastoma patients in a phase III COG immunotherapy trial.
暂无分享，去创建一个
J. Maris | KyungMann Kim | E. Mendonça | W. London | M. Hogarty | A. Yu | S. Gillies | R. Reisfeld | Julie R. Park | L. Carmichael | J. Hank | P. Sondel | A. Erbe | M. Ozkaynak | Wei Wang | Yiqiang Song | Dustin Hess | A. Gilman | Mitchell B Dicciani